(Q40094135)

17 September 2017

1 reference

title

Antidepressants: a clinical update for medical practitioners (English)

1 reference

17 September 2017

Antidepressants: A Clinical Update for Medical Practitioners (English)

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

14 August 2023

author name string

J. W. Richardson

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6144818

14 August 2023

E. Richelson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6144818

14 August 2023

language of work or name

English

0 references

publication date

1 May 1984

1 reference

full work available at URL

17 September 2017

https://api.elsevier.com/content/article/PII:S0025619612614293?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

https://api.elsevier.com/content/article/PII:S0025619612614293?httpAccept=text/plain

14 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

14 August 2023

1 reference

17 September 2017

volume

59

1 reference

17 September 2017

issue

5

1 reference

17 September 2017

page(s)

330-337

1 reference

Depression in Medical In-Patients

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Affective disorders in a US urban community: the use of research diagnostic criteria in an epidemiological survey

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The efficacy of antidepressant drugs. A review of research (1958-1972).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Primary affective disorder criteria and the endogenous-reactive distinction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The symptoms of major depressive illness

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Treatment of endogenous anxiety with phobic, hysterical, and hypochondriacal symptoms.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Treatment of Agoraphobia With Group Exposure In Vivo and Imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Amitriptyline in Migraine Prophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Protriptyline: an effective agent in the treatment of the narcolepsy- cataplexy syndrome and hypersomnia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Peripheral Diabetic Neuropathy Treated With Amitriptyline and Fluphenazine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Enhancement of propoxyphene-induced analgesia by doxepin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Clomipramine and Amitriptyline in the Treatment of Severe Pain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Control of enuresis with imipramine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Imipramine and methylphenidate treatments of hyperactive boys. A double-blind comparison

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Monoamine oxidase inhibitors: prescription and patient management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Comparative studies of psychological function in patients with advanced cancer--I. Self-reported depressive symptoms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The prevalence of emotional and cognitive dysfunction in a general medical population: using the MMSE, GHQ, and BDI.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

An Inventory for Measuring Depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Dexamethasone suppression tests in antidepressant treatment of melancholia. The process of normalization and test-retest reproducibility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Prediction of imipramine antidepressant response by a one-day dextro- amphetamine trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The methylphenidate test for differentiating desipramine-responsive from nortriptyline-responsive depression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Relationship between age and tricyclic antidepressant plasma levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Amitriptyline once daily vs three times daily in depressed outpatients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Antidepressants are weak competitive antagonists of histamine H2 receptors in dissociated brain tissue

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Effect of antidepressant drugs on serotonergic and adrenergic receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Antidepressants and liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Ventricular arrhythmias possibly aggravated by trazodone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

New antidepressant drugs and the seizure threshold

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Amoxapine overdose: report of two patients with severe neurologic damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Toward a rational pharmacotherapy of depression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Presynaptic adrenergic receptor sensitivity in depression. The effect of long-term desipramine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The interference of tricyclic antidepressants with the central hypotensive effect of clonidine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Cardiac effects of tricyclic antidepressant medication. A preliminary study of nortriptyline

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Cardiovascular and antidepressant effects of imipramine in the treatment of secondary depression in patients with ischemic heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

2-Chloro-11-(1-piperazinyl)dibenz[b, f] [1, 4]oxazepine (amoxapine), an antidepressant with antipsychotic properties--a possible role for 7-hydroxyamoxapine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Pharmacologic modulation of the whealing response to histamine in human skin: identification of doxepin as a potent in vivo inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Tricyclic antidepressants in the treatment of peptic ulcer disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Current concepts in ophthalmology: the glaucomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Mode of action of antidepressant drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

A primer on geriatric psychopharmacology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Delirium after abrupt withdrawal from doxepin: case report

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Withdrawal symptoms following dicontinuation of imipramine therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Do psychotherapy and pharmacotherapy for depression conflict? Empirical evidence from a clinical trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Lithium induces rapid relief of depression in tricyclic antidepressant drug non-responders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Estrogen Therapy for Severe Persistent Depressions in Women

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Potentiation of antidepressant effects by L-triiodothyronine in tricyclic nonresponders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

Efficacy and safety of induced seizures (EST) in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

The Treatment of Psychotic Major Depressive Disorder with Drugs and Electroconvulsive Therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0025-6196%2812%2961429-3

inferred from DOI database lookup

7 January 2021

based on heuristic

Use of the dexamethasone suppression test in depression

27

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

The relationship of therapeutic response to antidepressant plasma levels: an update

14 August 2023

32

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Clinical pharmacology of imipramine and related antidepressant compounds

14 August 2023

34

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Pharmacology of antidepressants in use in the United States

14 August 2023

40

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Antagonism by antidepressants of muscarinic acetylcholine receptors of human brain

14 August 2023

43

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Tricyclic antidepressants and histamine H1 receptors

14 August 2023

45

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Cardiovascular effects of antidepressants

14 August 2023

51

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Clinical characteristics of imipramine-induced orthostatic hypotension

14 August 2023

60

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

The use of tricyclic antidepressants in chronic gastrointestinal pain

14 August 2023

68

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

Withdrawal symptoms during the course of imipramine therapy

14 August 2023

74

1 reference

https://api.crossref.org/works/10.1016/S0025-6196(12)61429-3

14 August 2023

Identifiers

1 reference

17 September 2017

1 reference